These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient. Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376 [TBL] [Abstract][Full Text] [Related]
8. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Hauser E; Toifl K; Mad A; Bittner R Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369 [TBL] [Abstract][Full Text] [Related]
9. Creatine kinase test diagnostic accuracy in neonatal screening for Duchenne Muscular Dystrophy: A systematic review. de Freitas Nakata KC; da Silva Pereira PP; Salgado Riveros B Clin Biochem; 2021 Dec; 98():1-9. PubMed ID: 34626608 [TBL] [Abstract][Full Text] [Related]
10. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community. Verma S; Anziska Y; Cracco J Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320 [No Abstract] [Full Text] [Related]
11. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience]. Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342 [TBL] [Abstract][Full Text] [Related]
12. 50 years ago in the Journal of Pediatrics: the use of serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy. Proud CM J Pediatr; 2013 Dec; 163(6):1656. PubMed ID: 24274203 [No Abstract] [Full Text] [Related]
13. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Moat SJ; Bradley DM; Salmon R; Clarke A; Hartley L Eur J Hum Genet; 2013 Oct; 21(10):1049-53. PubMed ID: 23340516 [TBL] [Abstract][Full Text] [Related]
14. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype. Schwartz M; Hertz JM; Sveen ML; Vissing J Neurology; 2005 May; 64(9):1635-7. PubMed ID: 15883334 [TBL] [Abstract][Full Text] [Related]
15. [Screening for Duchenne muscular dystrophy in newborns in the Ningxia region]. Jing M; Wang Y; Jing XY; Mao XM Zhongguo Dang Dai Er Ke Za Zhi; 2024 Mar; 26(3):258-261. PubMed ID: 38557377 [TBL] [Abstract][Full Text] [Related]
17. Should creatine kinase be checked in all boys presenting with speech delay? Lundy CT; Doherty GM; Hicks EM Arch Dis Child; 2007 Jul; 92(7):647-9. PubMed ID: 17588982 [No Abstract] [Full Text] [Related]
18. A new day for Duchenne's?: The time has come for newborn screening. Pillers DA Mol Genet Metab; 2014; 113(1-2):11-3. PubMed ID: 24974086 [No Abstract] [Full Text] [Related]
19. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy. Mendell JR; Lloyd-Puryear M Muscle Nerve; 2013 Jul; 48(1):21-6. PubMed ID: 23716304 [TBL] [Abstract][Full Text] [Related]
20. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy. Dubowitz V Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656 [No Abstract] [Full Text] [Related] [Next] [New Search]